// App-Quantinova.ai

DXT68 : Real-World Infection Rates and Lymphocyte Counts in Patients ≥50 Years with Relapsing-Remitting MS Treated with Subcutaneous Interferon beta-1a or Dimethyl Fumarate

Researchers

Presenter

  • Brooke Hayward

Principal Investigators

  • Sarah Cardoso

  • Megan Grosso

  • Soudeh Ansari

  • Salvatore Napoli

Medical Centers

  • Neurology Center of New England

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Interferon

Drug/Treatment

  • Interferon beta-1a

  • Dimethyl fumarate

  • Interferon Beta

  • Interferon

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • EMD Serono Inc

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved